Abstract

The debate over generic drug substitution is not a new issue to our society. For years health care professionals have argued both for and against generic drug substitution for brand name medications, highlighting such concerns as price and efficacy to prove their ethical stance on the matter. While many argue that generics work in an equivalent manner to brand name counterparts, some remain strong with the idea that generic drug substitution is both dangerous and irresponsible in many cases. It is this stance which this thesis will defend. Within this thesis, there will be a focus on the substitution of generic drugs from a variety of platforms, including biophysical, financial, and research implications of the current FDA policies particularly as they concern narrow therapeutic index drugs, ultimately proving the unethical nature of the system and suggesting methods by which this system may be revised.

Semester/Year of Award

Spring 2015

Mentor

Laura Newhart

Department/Professional Affiliation

Philosophy and Religion

Access Options

Restricted Access Thesis

Degree Name

Honors Scholars

Department

Chemistry

Share

COinS